DSIP (Delta Sleep-Inducing Peptide): Complete Guide for Dubai & UAE (2026)
DSIP (Delta Sleep-Inducing Peptide): Complete Guide for Dubai & UAE (2026)
DSIP is a nonapeptide originally isolated from rabbit cerebral venous blood during natural sleep. It remains one of the most studied neuropeptides for sleep architecture research — distinct from sedatives in that it promotes quality delta-wave sleep rather than sedation. This guide covers what UAE-based researchers need to know about DSIP's mechanism, forms, dosing, and availability.
What Is DSIP?
Delta Sleep-Inducing Peptide (DSIP) is a nine amino acid neuropeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) that modulates sleep architecture by promoting slow-wave (delta-wave) sleep — the deepest, most restorative phase of sleep associated with growth hormone release, tissue repair, and immune consolidation.
Unlike benzodiazepines or Z-drugs which induce sedation by enhancing GABA-A receptor activity, DSIP works through multiple neuromodulatory pathways including GABA, NMDA receptors, and serotonergic systems — promoting natural sleep architecture without the dependency or morning grogginess associated with pharmaceutical sleep aids.
Mechanism of Action
- Delta-wave promotion: DSIP modulates GABAergic and serotonergic neurotransmission to increase slow-wave sleep duration and depth — the phase associated with GH secretion and cellular repair
- Stress modulation: DSIP suppresses corticotropin (ACTH) release and modulates hypothalamic-pituitary-adrenal (HPA) axis activity — reducing cortisol in stress models, which directly improves sleep initiation
- NMDA receptor interaction: DSIP modulates NMDA receptor activity, which influences sleep-wake transitions and may contribute to its neuroprotective properties
- Antioxidant activity: Research shows DSIP reduces oxidative stress markers — relevant for its reported neuroprotective effects beyond sleep regulation
DSIP Research Dosing & Forms
| Form | Dose | Administration |
|---|---|---|
| Injectable vial | 5 mg | 25–100 mcg subcutaneous, 30–60 min before sleep |
| Nasal spray | 5 mg | 25–50 mcg intranasal, 30 min before sleep |
DSIP has a short plasma half-life (approximately 30–40 minutes IV), which is why administration is timed close to the sleep window. Intranasal delivery provides direct CNS access via the olfactory pathway, making it a clinically relevant route despite lower systemic bioavailability.
DSIP vs Pharmaceutical Sleep Aids
- No sedation: DSIP does not sedate — it promotes natural delta sleep architecture without disrupting REM sleep or causing morning impairment
- No dependency: Unlike benzodiazepines, DSIP does not produce physical dependence or withdrawal in research models
- Cortisol reduction: The cortisol-suppressing effect addresses one of the most common physiological causes of poor sleep quality (elevated evening cortisol), making DSIP useful for stress-related insomnia research
- GH secretion: By extending deep sleep, DSIP indirectly supports natural growth hormone pulsatility — making it of research interest for recovery and anti-aging protocols
Storage
Lyophilised DSIP powder: refrigerate at 4°C or freeze at −20°C. Reconstituted solution: refrigerate and use within 30 days. Nasal spray: refrigerate. DSIP is stable in lyophilised form but degrades more rapidly in solution at room temperature.
Related Products
Buy DSIP in Dubai & UAE
Injectable vial and nasal spray — cGMP sourced, ≥99% HPLC purity, COA available.
Shop DSIPFrequently Asked Questions
Yes — DSIP + MK-677 is a studied sleep and recovery stack. DSIP promotes deep sleep architecture while MK-677 amplifies the GH pulse that occurs during slow-wave sleep. The combination is used in sleep quality and GH secretion research.
Onset of sleep-promoting effects is typically 30–60 minutes after administration. Some researchers report cumulative improvement in sleep architecture over 5–10 consecutive nights of administration.
Yes — DSIP suppresses ACTH-stimulated cortisol release in research models. This is clinically relevant because elevated evening cortisol is one of the most common physiological barriers to deep sleep onset.
CoreSup stocks pharmaceutical-grade bacteriostatic water (10ml, 0.9% benzyl alcohol) with same-day delivery across Dubai and all UAE emirates.
Shop Bacteriostatic Water →Disclaimer: This article is for educational and research purposes only. Products mentioned are research compounds not approved by UAE MOHAP or the FDA for human therapeutic use. Nothing herein constitutes medical advice. Consult a licensed UAE healthcare professional before beginning any peptide protocol.
Written by Core Sup Research Team
Core Sup Research Team · Peptide & Supplement Specialists, Dubai UAE
Core Sup's editorial team is composed of specialists in peptide therapy, SARMs, and sports supplementation with direct experience in the UAE market. All content is written to current research standards and reviewed before publication.
Last reviewed: April 2026 · About Core Sup
